Literature DB >> 11095336

Birth outcomes of women with ulcerative colitis: a nationwide Danish cohort study.

B Nørgård1, K Fonager, H T Sørensen, J Olsen.   

Abstract

OBJECTIVE: Our study aimed to compare the birth outcomes in offspring of women with ulcerative colitis with controls without the disease.
METHODS: A cohort study of 1531 newborns to mothers with ulcerative colitis, and 9092 controls, based on linkage between the Danish National Registry of Patients and the Danish Birth Registry from 1982 to 1992.
RESULTS: Among the births to women with ulcerative colitis, 569 took place before and 962 after the first hospitalization for ulcerative colitis. We found no increased risk of either low birth weight or intrauterine growth retardation for newborns born before or after the mothers' first hospitalization. The risk of preterm birth was increased when birth occurred after the mothers' first hospitalization (odds ratio = 1.4, 95% confidence interval = 1.1-1.9), and particularly when the first hospitalization for ulcerative colitis took place during pregnancy (odds ratio = 3.4, 95% confidence interval = 1.8-6.4).
CONCLUSIONS: In the offspring of women with ulcerative colitis, we found no increased risk of low birth weight or signs of intrauterine growth retardation. The risk of preterm birth was increased in the offspring of women with ulcerative colitis, particularly when the first hospitalization for ulcerative colitis occurred during pregnancy.

Entities:  

Mesh:

Year:  2000        PMID: 11095336     DOI: 10.1111/j.1572-0241.2000.03290.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  22 in total

Review 1.  Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases.

Authors:  Lori M Gawron; Jessica Sanders; Katelyn P Steele; Ann D Flynn
Journal:  Inflamm Bowel Dis       Date:  2016-02       Impact factor: 5.325

Review 2.  Fertility and pregnancy in the patient with inflammatory bowel disease.

Authors:  U Mahadevan
Journal:  Gut       Date:  2006-08       Impact factor: 23.059

Review 3.  A meta-analysis on the influence of inflammatory bowel disease on pregnancy.

Authors:  J Cornish; E Tan; J Teare; T G Teoh; R Rai; S K Clark; P P Tekkis
Journal:  Gut       Date:  2006-12-21       Impact factor: 23.059

4.  Documentation of reproductive health counseling and contraception in women with inflammatory bowel diseases.

Authors:  Lori M Gawron; Cassing Hammond; Laurie Keefer
Journal:  Patient Educ Couns       Date:  2013-09-27

5.  Inadequate Gestational Weight Gain Predicts Adverse Pregnancy Outcomes in Mothers with Inflammatory Bowel Disease: Results from a Prospective US Pregnancy Cohort.

Authors:  May-Bente Bengtson; Christopher F Martin; Geir Aamodt; Morten H Vatn; Uma Mahadevan
Journal:  Dig Dis Sci       Date:  2017-03-22       Impact factor: 3.199

6.  Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel Disease.

Authors:  Kristin E Burke; Miriam J Haviland; Michele R Hacker; Scott A Shainker; Adam S Cheifetz
Journal:  Inflamm Bowel Dis       Date:  2017-05       Impact factor: 5.325

7.  Inflammatory bowel disease in pregnancy.

Authors:  Dawn B Beaulieu; Sunanda Kane
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

8.  Dietary Patterns in women with Inflammatory Bowel Disease and Risk of Adverse Pregnancy Outcomes: Results from The Norwegian Mother and Child Cohort Study (MoBa).

Authors:  Thea Myklebust-Hansen; Geir Aamodt; Margaretha Haugen; Anne Lise Brantsæter; Morten H Vatn; May-Bente Bengtson
Journal:  Inflamm Bowel Dis       Date:  2017-12-19       Impact factor: 5.325

Review 9.  Contraceptive Considerations for Women with Gastrointestinal Disorders.

Authors:  Aparna Sridhar; Carrie A Cwiak; Andrew M Kaunitz; Rebecca H Allen
Journal:  Dig Dis Sci       Date:  2016-11-24       Impact factor: 3.199

Review 10.  Safety of anti-tumor necrosis factor therapy during pregnancy in patients with inflammatory bowel disease.

Authors:  Ioannis Androulakis; Christos Zavos; Panagiotis Christopoulos; George Mastorakos; Maria Gazouli
Journal:  World J Gastroenterol       Date:  2015-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.